Hjem › Hemofili B › Michigan
Kliniske studier for Hemofili B i Michigan
6 studier for Hemofili B søker deltakere på steder i Michigan.
Byer i Michigan
Offisiell studietekst (engelsk)
Phase 3, Open-label, Single-dose Study of CSL222 in Adolescent Male Subjects (≥ 12 to < 18 Years of Age) With Severe or Moderately Severe Hemophilia B
- University of Michigan Medical Center, Ann Arbor
RekruttererFase 3
138 Months – 206 Months · Menn · Oppdatert 16. sep. 2026 · NCT07080905A Study to Investigate the Safety and Effectiveness of a Coagulation Factor IX Gene Insertion Therapy (REGV131-LNP1265) in Pediatric, Adolescent and Adult Participants With Hemophilia B
- University of Michigan, Ann Arbor
RekruttererFase 1/2
Alder 2 og eldre · Menn · Oppdatert 11. sep. 2026 · NCT06379789Efficacy and Safety of CSL222 (Etranacogene Dezaparvovec) Gene Therapy in Adults With Hemophilia B With Pretreatment Adeno-associated Virus Serotype 5 (AAV5) Neutralizing Antibodies (Nabs)
- University of Michigan, Ann Arbor
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 27. aug. 2026 · NCT06003387ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
- Central Michigan Children's Hospital of Michigan, Detroit
- Henry Ford Health System Bleeding and Thrombosis Treatment Center, Detroit
RekruttererObservasjonsstudie
Alle aldre · Alle kjønn · Oppdatert 17. aug. 2026 · NCT04398628A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SR604 in Two Participants Groups (Part A: Healthy Participants, and Part B: Participants With Hemophilia A or Hemophilia B or Factor VII Deficiency)
- University of Michigan Hospitals - Michigan Medicine, Ann Arbor
RekruttererFase 1Frivillige helsepersonell ønskes velkommen
Alder 18 til 60 · Alle kjønn · Oppdatert 2. jul. 2026 · NCT06349473SEVENFACT® for Bleeding Events in Hemophilia With Inhibitors
- Children's Hospital of Michigan, Detroit
- Henry Ford Health System, Detroit
- MSU Center for Bleeding and Clotting Disorders, Lansing
RekruttererFase 4
Alder 12 til 100 · Alle kjønn · Oppdatert 12. jan. 2026 · NCT04647227Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.